Learn more

CALIFORNIA PACIFIC MED CENTER

Overview
  • Total Patents
    89
About

CALIFORNIA PACIFIC MED CENTER has a total of 89 patent applications. Its first patent ever was published in 1993. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are UNIVERSITAETSKLINIKUM MUENSTER, IST NAZ STUD CURA DEI TUMORI and SECOND GENOME INC.

Patent filings per year

Chart showing CALIFORNIA PACIFIC MED CENTERs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Yang Li-Xi 34
#2 Pan Xiandao 12
#3 Wang Huijuan 10
#4 Drummond Daryl C 9
#5 Kirpotin Dmitri B 9
#6 Lee Nancy M 8
#7 Hong Keelung 8
#8 Chen Ling-Chun 8
#9 Smith Helene S 6
#10 Dairkee Shanaz H 5

Latest patents

Publication Filing date Title
WO2009021150A2 Platelet derived growth factor receptor supports cytomegalovirus infectivity
WO2008154532A1 Method and kit for dynamic gene expression monitoring
CN101772581A Method to predict or diagnose a gastrointestinal disorder or disease
WO2008144475A1 Methods and compositions for treating cancer
EP1946007A2 Anbrosteeone derivatives and method of use thereof
WO2007041397A2 Targeted pharmaceuticals and ligands
WO2006138717A2 Methods and apparatus for determining proportions of body materials
WO2006034227A2 Face mask
US2005014165A1 Biomarker panel for colorectal cancer
US7342114B2 Podophyllotoxin derivatives
WO03101998A1 Nitrogen-based homo-camptothecin derivatives
AU2003243397A1 Homo-camptothecin derivatives
US6825236B2 Colchicine derivatives
US6855720B2 Nitrogen-based camptothecin derivatives
US7056663B2 Prognostic methods for breast cancer
US6403604B1 Nitrogen-based camptothecin derivatives
US6350756B1 Camptothecin derivatives
WO0157061A1 Novel use of ribozymes to block gene expression
US6423707B1 Nitroimidazole ester analogues and therapeutic applications
AU5474899A Genes amplified in cancer cells